These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 765621

  • 1. Nonessential role of neutrophils as mediators of hyperacute cardiac allograft rejection in the rat.
    Forbes RD, Guttmann RD, Kuramochi T, Klassen J, Knaack J.
    Lab Invest; 1976 Mar; 34(3):229-34. PubMed ID: 765621
    [Abstract] [Full Text] [Related]

  • 2. Hyperacute rejection of cardiac allografts in a rat strain with a hereditary platelet function defect.
    Forbes RD, Guttmann RD, Bazin H.
    Lab Invest; 1977 Aug; 37(2):158-61. PubMed ID: 329001
    [Abstract] [Full Text] [Related]

  • 3. A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat.
    Forbes RD, Kuramochi T, Guttmann RD, Klassen J, Knaack J.
    Lab Invest; 1975 Sep; 33(3):280-8. PubMed ID: 1099337
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection.
    Zehr KJ, Herskowitz A, Lee PC, Poston RS, Gillinov AM, Baumgartner WA.
    J Heart Lung Transplant; 1993 Sep; 12(5):837-44; discussion 844-5. PubMed ID: 8241225
    [Abstract] [Full Text] [Related]

  • 5. Controlled studies of the pathogenesis of hyperacute cardiac allograft rejection in actively immunized recipients.
    Forbes RD, Guttmann RD, Kuramochi T.
    Transplant Proc; 1977 Mar; 9(1):301-3. PubMed ID: 325771
    [No Abstract] [Full Text] [Related]

  • 6. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF, Tezuka K, Wasfie T, Stegall MD, Reemtsma K, Hardy MA.
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [Abstract] [Full Text] [Related]

  • 7. The effect of anticomplementary cobra venom factor on hyperacute rat cardiac allograft rejection.
    Forbes RD, Pinto-Blonde M, Guttmann RD.
    Lab Invest; 1978 Nov; 39(5):463-70. PubMed ID: 366280
    [Abstract] [Full Text] [Related]

  • 8. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB, Baldwin WM, Ibrahim S, Sanfilippo F.
    Transplantation; 1995 Jan 27; 59(2):288-93. PubMed ID: 7839453
    [Abstract] [Full Text] [Related]

  • 9. Use of donor serum to prevent passive transfer of hyperacute rejection.
    Wang J, Geissler EK, Fechner JH, Burlingham WJ, Knechtle SJ.
    J Surg Res; 1994 Jul 27; 57(1):150-5. PubMed ID: 8041130
    [Abstract] [Full Text] [Related]

  • 10. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H, Backer CL, Crawford SE, Zales VR, Mavroudis C.
    J Heart Lung Transplant; 1995 Jul 27; 14(3):529-36. PubMed ID: 7654736
    [Abstract] [Full Text] [Related]

  • 11. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
    Ito S, Camussi G, Tetta C, Milgrom F, Andres G.
    Lab Invest; 1984 Aug 27; 51(2):148-61. PubMed ID: 6379289
    [Abstract] [Full Text] [Related]

  • 12. Heat shock protein 70 expression in native and heterotopically transplanted rat hearts.
    Mehta NK, Carroll M, Sykes DE, Tan Z, Bergsland J, Canty J, Bhayana JN, Hoover EL, Salerno TA.
    J Surg Res; 1997 Jul 01; 70(2):151-5. PubMed ID: 9245564
    [Abstract] [Full Text] [Related]

  • 13. Heat shock protein reactivity of lymphocytes isolated from heterotopic rat cardiac allografts.
    Moliterno R, Valdivia L, Pan F, Duquesnoy RJ.
    Transplantation; 1995 Feb 27; 59(4):598-604. PubMed ID: 7878764
    [Abstract] [Full Text] [Related]

  • 14. Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. An experimental study.
    Sharma HM, Rosensweig J, Chatterjee S, Moore S, De Champlain ML.
    Am J Pathol; 1973 Feb 27; 70(2):155-74. PubMed ID: 4566989
    [Abstract] [Full Text] [Related]

  • 15. A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction.
    Forbes RD, Guttmann RD, Gomersall M, Hibberd J.
    Am J Pathol; 1983 May 27; 111(2):184-96. PubMed ID: 6342410
    [Abstract] [Full Text] [Related]

  • 16. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC.
    J Heart Lung Transplant; 1995 May 27; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [Abstract] [Full Text] [Related]

  • 17. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
    Washburn WK, Otsu I, Gottschalk R, Monaco AP.
    J Surg Res; 1996 May 27; 62(2):179-83. PubMed ID: 8632636
    [Abstract] [Full Text] [Related]

  • 18. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y, Mori K, Bollinger RR.
    J Clin Lab Immunol; 1990 Jun 27; 32(2):59-66. PubMed ID: 1967040
    [Abstract] [Full Text] [Related]

  • 19. Fetal inoculation with donor cells in cardiac xenotransplantation.
    Shen Z, Mohiuddin M, DiSesa VJ.
    Ann Thorac Surg; 1996 Nov 27; 62(5):1360-3. PubMed ID: 8893569
    [Abstract] [Full Text] [Related]

  • 20. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
    Adams DH, Tilney NL, Collins JJ, Karnovsky MJ.
    Transplantation; 1992 May 27; 53(5):1115-9. PubMed ID: 1585476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.